The Validity of Objective Response Rate As A Surrogate For Progression-Free And Overall Survival In The Evaluation of First-Line Chemotherapy For Advanced Non-Small Cell Lung Cancer
Abstract
Authors
SM Goring A Briggs JR Penrod S Fan N Waser J Thompson JB Wilson S Wang B Korytowsky O Chirita N Hertel Y Yuan